Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rheumatoid Arthritis
Pharma
J&J's Imaavy comes up short in rheumatoid arthritis study
Flying high after an FDA approval to treat gMG, J&J's Imaavy has come up short as part of a combination therapy in a rheumatoid arthritis trial.
Kevin Dunleavy
Aug 29, 2025 10:56am
AbbVie makes 'Rheum for Dialogue' with new patient resource
Nov 18, 2024 10:20am
Galapagos sells its Jyseleca business to Italy's Alfasigma
Oct 31, 2023 9:10am
Biogen nabs FDA nod for biosimilar of Roche blockbuster Actemra
Oct 2, 2023 10:42am
Roche sues Biogen over Actemra biosimilar infringement claims
Jul 17, 2023 9:45am
With FDA nod for Crohn's, AbbVie wins 7th indication for Rinvoq
May 18, 2023 4:25pm
